Physician profile
Michael E Damrich
NPI 1063560563
$2,594.62
in general payments reported to CMS, 2019-2025
12 companies · $871 in 2025
The $871 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $219 · 2021: $169 · 2022: $452 · 2023: $33.03 · 2024: $310 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,214.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $812.67 | 2019-2025 | Varithena Administration Pack |
| Medtronic, INC. | $588.82 | 2021-2025 | Valiant Captivia, Endurant Iis |
| Medtronic Vascular, INC. | $260.17 | 2019 | |
| Abiomed | $186.14 | 2024-2025 | Impella |
| Penumbra, INC. | $170.90 | 2022 | |
| Cvrx, INC. | $158.40 | 2025 | Barostim Neo System |
| Bolton Medical INC | $142.60 | 2022-2024 | Treo Abdominal Stent-Graft System |
| Baxter Healthcare | $104.71 | 2021 | |
| Shape Memory Medical INC. | $100.78 | 2025 | Impede Embolization Plug |
| Davol INC. | $34.28 | 2020 | |
| Atricure, INC. | $20.62 | 2024 | |
| Chiesi USA, INC. | $14.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Damrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.